To evaluate the sensitivity of the MTCP1-driven murine leukemia to ibrutinib, Eμ-MTCP1 pups from founder line Z36 were treated continuously from the time of weaning with drinking water containing ibrutinib at ∼30 mg/kg/day or 10% cyclodextrin (vehicle). The gene discussed is MTCP1; the disease is leukemia.